Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Compare cost structures of Index Funds and Target Date Funds to determine which option offers lower long-term expenses for retirement savers.
25,451 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A biotech name drops sharply after mixed obesity data, sending Wave Life Sciences and the broader market into a brief...
Policymakers are weighing tax shifts that could touch luxury spending by the ultra-wealthy. Investors watch designer ...
Curious if you can own SpaceX stock before its IPO through Hyperliquid? This guide explains why that pre-IPO thrill o...
As incoming Fed Chair Warsh signals a renewed focus on inflation, traders weigh the odds of higher-for-longer policy ...
Hedge funds are the most bearish on the yen since 2007, setting the stage for a potential shift into crypto. XRP coul...
ServiceNow stock edged past the market as an analyst upgrade lifted sentiment. This article breaks down what moved NO...
Oil prices have slipped below $70 even as shipping tensions threaten the Strait of Hormuz. This guide explains what d...
Argentina presses ahead with sweeping reforms, betting on privatizations and tighter budgets. Investors are turning t...
DES delivers monthly payouts tied to a cash-dividend weighted small-cap index. The income looks reliable, but a conce...
This guide shares a real-world route to achieve from zero $8,000/month cash flow while working a full-time job. Learn...
Anthropic, the Claude-maker, confidentially files to go public, igniting talk of a potential trillion-dollar valuatio...